Kelley, M.J

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell

Bone Metabolism and DiseasesRheumatoid Arthritis Research and Therapies

Cited by 5,439

197 POSTER Denosumab is a selective inhibitor of human receptor activator of NF-kB ligand that blocks osteoclast formation in vitro and in vivo

Elliott, R., Kostenuik, P., Chen, C., Kelley, M., Hawkins, N., Housman, J., McCabe, S., Mukku, V., Sullivan, J., & Dougall, W. (2006) · European Journal of Cancer Supplements

Head and Neck Cancer StudiesBone health and treatments

Cited by 14